Optoaspis is a novel nutritional supplement for the management of glaucoma. It has a binary mechanism of action in managing and slowing the progression of patients with glaucoma. Optoaspis is based on solid clinical research and has a holistic approach. In addition, Optoaspis is produced with a controlled release technology (retard form) that permits the maintenance of active ingredients in blood circulation at stable quantities, resulting in a prolonged treatment duration and availability of the ingredients.
The ingredients of Optoaspis have a strong antioxidant and neuroprotective effect in order to reduce the intraocular pressure and increase the blood flow around the optic nerve.
The product should not be used as a substitute of a well-balanced diet. This product is not intended to prevent, treat or cure any human disease.